Nelson Advisors invited as a Guest Speaker to Future Health Intelligence's 'Winners and Losers in the AVT Goldrush' event

Nelson Advisors have been invited as a Guest Speaker to Future Health Intelligence's ' Winners and Losers in the AVT Goldrush' event on Friday 13th November 2026.

Source: https://futurehealthintelligence.com/webinars/

https://events.teams.microsoft.com/event/a22867d5-8a83-4aa9-a40c-3561d8d7d386@afd73091-8905-492b-85fc-565d55690b0b?source=copyLinkLegacyShareLinkDialog

Ambient voice has moved from pilot to procurement faster than any NHS technology in recent memory.  Clinician adoption has been rapid but where is the market heading next?

NHS England is backing AVT as a national priority that as part of the £10bn digital left shift.
The Midlands is procuring for around 70,000 clinicians.
Wales has a £10m framework due to award on 30 November.
The money is real, and the buyers are moving.

But look closely at one word: integrated. If national policy favours AVT that sits inside the EPR, ambient voice stops being a product and becomes a feature. Oracle, Epic and the other EPR suppliers are building native tools. Once those are good enough, why would a trust keep buying a separate scribe?

Using the FHI AVT contract dashboard, we'll show who has won so far by supplier, trust, route and value. Then we'll ask the commercial question every vendor and investor in this space needs answered: how long does the standalone window stay open?

You'll leave knowing:

Who is winning NHS AVT contracts, and through which routes
Which trusts and regions have bought, and which are still open
What the Midlands and Wales procurements signal about how the national market will form
Whether "integrated" changes the game, and what standalone vendors can do in the time they have left
What is the evidence of benefits of AVT from early adopters and what are the known pitfalls?